SCHEMBL7079124

SCHEMBL7079124

COC(=O)CC(CS(=O)(=O)c1ccc(Br)cc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
POLB P06746 4/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.42
MMP2 P08253 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PSMD14 O00487 1/20 0.42
DNMT1 P26358 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MMP13 P45452 2/20 0.42
MMP3 P08254 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
KCNA5 P22460 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7073376 0.88 ALDH1A1 (0.46) ALDH1A1KMT2AMMP2MMP13MMP3
SCHEMBL7074900 0.88 F2 (0.45) ALDH1A1POLBKMT2AGAALMNA
SCHEMBL7079059 0.87 ALDH1A1 (0.45) ALDH1A1POLBKMT2AMEN1LMNA
SCHEMBL7077837 0.84 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1GAALMNA
SCHEMBL7075400 0.82 F2 (0.45) ALDH1A1POLBGAAMMP2KDM4E
SCHEMBL7079922 0.82 MMP2 (0.43) ALDH1A1MMP2MMP13MMP3PDE4A
SCHEMBL7078814 0.82 MMP13 (0.48) ALDH1A1MMP2MMP13MMP3PDE4A
SCHEMBL7073767 0.81 MMP13 (0.49) ALDH1A1KMT2AMEN1MMP2TDP1
SCHEMBL7078057 0.79 HSD11B1 (0.48) ALDH1A1POLBKMT2AMEN1GAA
SCHEMBL7078648 0.79 FNTA (0.54) ALDH1A1KMT2AMEN1LMNAMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed